Policy & Medicine

Legal, Regulatory, and Compliance Issues

facebook
twitter
google_plus
Email

Browsing daily archive

May 2, 2019

FTC Finds Impax-Endo “No Approved Generic” Agreement to be Anticompetitive Pay-For-Delay Scheme

Open Payments
Litigation
FDA
CME
Opioids
International
State Policy
Transparency
COVID-19
CMS
MACRA

View Desktop Version